id
stringlengths 11
11
| tags
stringlengths 10
777
| text
stringlengths 2
1.5k
| dataset_num
int64 1
3
| tokens
list | ner_tags
list |
|---|---|---|---|---|---|
NCT03073070
|
16:34:treatment,
|
consumption of biotin supplements or raw eggs within 30 days
| 1
|
[
"consumption",
"of",
"biotin",
"supplements",
"or",
"raw",
"eggs",
"within",
"30",
"days"
] |
[
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT01807091
|
,,,87:99:treatment
|
Treatment-related mortality (TRM) score < 9.21 corresponding to a TRM rate of 3% when chemotherapy of similar intensity as proposed here is administered to inpatients
| 1
|
[
"Treatment-related",
"mortality",
"(",
"TRM",
")",
"score",
"<",
"9.21",
"corresponding",
"to",
"a",
"TRM",
"rate",
"of",
"3",
"%",
"when",
"chemotherapy",
"of",
"similar",
"intensity",
"as",
"proposed",
"here",
"is",
"administered",
"to",
"inpatients"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02338999
|
22:37:chronic_disease,48:51:chronic_disease,48:57:chronic_disease,,,137:150:chronic_disease,164:192:treatment,201:212:chronic_disease,366:381:treatment
|
Patients with active lupus nephritis or active CNS lupus at baseline even if SLEDAI-2K <20. Active disease will be considered as CNS or renal disease that require aggressive immunosuppression. Active CNS disease will be diagnosed based on clinical presentation and physical exam, exclusion of other conditions that could explain symptomatology and, when warranted, ancillary tests (imaging) that support the diagnosis
| 1
|
[
"Patients",
"with",
"active",
"lupus",
"nephritis",
"or",
"active",
"CNS",
"lupus",
"at",
"baseline",
"even",
"if",
"SLEDAI-2K",
"<",
"20",
".",
"Active",
"disease",
"will",
"be",
"considered",
"as",
"CNS",
"or",
"renal",
"disease",
"that",
"require",
"aggressive",
"immunosuppression",
".",
"Active",
"CNS",
"disease",
"will",
"be",
"diagnosed",
"based",
"on",
"clinical",
"presentation",
"and",
"physical",
"exam",
",",
"exclusion",
"of",
"other",
"conditions",
"that",
"could",
"explain",
"symptomatology",
"and",
",",
"when",
"warranted",
",",
"ancillary",
"tests",
"(",
"imaging",
")",
"that",
"support",
"the",
"diagnosis"
] |
[
0,
0,
0,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT00719888
|
12:56:chronic_disease
|
History of human immunodeficiency virus (HIV) infection
| 1
|
[
"History",
"of",
"human",
"immunodeficiency",
"virus",
"(",
"HIV",
")",
"infection"
] |
[
0,
0,
2,
2,
2,
2,
2,
0,
0
] |
NCT02837510
|
1:17:treatment,19:29:treatment,31:37:treatment,66:71:treatment,73:83:treatment,84:89:treatment
|
Anti-depressants (tricyclics, SSRI's, selective and nonselective MAOIs, Wellbutrin/Zyban)
| 1
|
[
"Anti-depressants",
"(",
"tricyclics",
",",
"SSRI",
"'s",
",",
"selective",
"and",
"nonselective",
"MAOIs",
",",
"Wellbutrin/Zyban",
")"
] |
[
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
NCT02946892
|
1:50:chronic_disease,67:79:treatment,97:122:treatment
|
Sustained or symptomatic ventricular dysrhythmias uncontrolled by drug therapy or the use of an implantable defibrillator
| 1
|
[
"Sustained",
"or",
"symptomatic",
"ventricular",
"dysrhythmias",
"uncontrolled",
"by",
"drug",
"therapy",
"or",
"the",
"use",
"of",
"an",
"implantable",
"defibrillator"
] |
[
2,
2,
2,
2,
2,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
1
] |
NCT02064036
|
1:26:treatment
|
Previous hormonal therapy
| 1
|
[
"Previous",
"hormonal",
"therapy"
] |
[
1,
1,
1
] |
NCT02204098
|
1:13:treatment
|
Chemotherapy
| 1
|
[
"Chemotherapy"
] |
[
1
] |
NCT02089607
|
17:31:treatment
|
Native aorta or surgical graft
| 1
|
[
"Native",
"aorta",
"or",
"surgical",
"graft"
] |
[
0,
0,
0,
1,
1
] |
NCT01872975
|
101:120:treatment,149:175:treatment,211:238:treatment,263:277:cancer
|
Patient must have had pathologic confirmation of axillary nodal involvement at presentation (before neoadjuvant therapy) based on either a positive fine needle aspirate (FNA) (demonstrating malignant cells) or positive core needle biopsy (demonstrating invasive adenocarcinoma)
| 1
|
[
"Patient",
"must",
"have",
"had",
"pathologic",
"confirmation",
"of",
"axillary",
"nodal",
"involvement",
"at",
"presentation",
"(",
"before",
"neoadjuvant",
"therapy",
")",
"based",
"on",
"either",
"a",
"positive",
"fine",
"needle",
"aspirate",
"(",
"FNA",
")",
"(",
"demonstrating",
"malignant",
"cells",
")",
"or",
"positive",
"core",
"needle",
"biopsy",
"(",
"demonstrating",
"invasive",
"adenocarcinoma",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0
] |
NCT02415387
|
1:7:chronic_disease
|
Anemia
| 1
|
[
"Anemia"
] |
[
2
] |
NCT02974257
|
,20:34:chronic_disease
|
Within 12 hours of cardiac arrest event
| 1
|
[
"Within",
"12",
"hours",
"of",
"cardiac",
"arrest",
"event"
] |
[
0,
0,
0,
0,
2,
2,
0
] |
NCT02393794
|
,,91:100:treatment
|
their partners must use contraception prior to study entry, continuing for 5 months after treatment
| 1
|
[
"their",
"partners",
"must",
"use",
"contraception",
"prior",
"to",
"study",
"entry",
",",
"continuing",
"for",
"5",
"months",
"after",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03016351
|
12:59:chronic_disease
|
History of cardiovascular disease or cardiovascular events
| 1
|
[
"History",
"of",
"cardiovascular",
"disease",
"or",
"cardiovascular",
"events"
] |
[
0,
0,
2,
2,
2,
2,
2
] |
NCT03056339
|
29:32:chronic_disease
|
Known positive serology for HIV
| 1
|
[
"Known",
"positive",
"serology",
"for",
"HIV"
] |
[
0,
0,
0,
0,
2
] |
NCT03175159
|
1:4:chronic_disease
|
HIV-uninfected
| 1
|
[
"HIV-uninfected"
] |
[
2
] |
NCT02464878
|
1:35:chronic_disease,,,
|
Selective or severe IgA deficiency (levels < 5-7 mg/dL)
| 1
|
[
"Selective",
"or",
"severe",
"IgA",
"deficiency",
"(",
"levels",
"<",
"5-7",
"mg/dL",
")"
] |
[
2,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02901041
|
32:45:treatment
|
Must be willing to discontinue psychotherapy for substance use disorder (except A.A.)
| 1
|
[
"Must",
"be",
"willing",
"to",
"discontinue",
"psychotherapy",
"for",
"substance",
"use",
"disorder",
"(",
"except",
"A.A",
".",
")"
] |
[
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02329652
|
1:9:chronic_disease
|
diabetes or any condition which requires frequent blood pressure monitoring or frequent venipuncture
| 1
|
[
"diabetes",
"or",
"any",
"condition",
"which",
"requires",
"frequent",
"blood",
"pressure",
"monitoring",
"or",
"frequent",
"venipuncture"
] |
[
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00909909
|
24:33:cancer,35:41:cancer,35:40:cancer,,175:193:cancer,230:240:cancer,244:250:treatment
|
No proven multicentric carcinoma (tumors in different quadrants of the breast or tumor separated by ≥ 4 cm) with other clinically or radiographically suspicious areas in the ipsilateral breast unless confirmed to be negative for malignancy by biopsy
| 1
|
[
"No",
"proven",
"multicentric",
"carcinoma",
"(",
"tumors",
"in",
"different",
"quadrants",
"of",
"the",
"breast",
"or",
"tumor",
"separated",
"by",
"≥",
"4",
"cm",
")",
"with",
"other",
"clinically",
"or",
"radiographically",
"suspicious",
"areas",
"in",
"the",
"ipsilateral",
"breast",
"unless",
"confirmed",
"to",
"be",
"negative",
"for",
"malignancy",
"by",
"biopsy"
] |
[
0,
0,
0,
3,
0,
3,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
3,
0,
1
] |
NCT01952730
|
1:19:cancer
|
Hepatic metastases involving both branches of the portal vein or all three hepatic veins
| 1
|
[
"Hepatic",
"metastases",
"involving",
"both",
"branches",
"of",
"the",
"portal",
"vein",
"or",
"all",
"three",
"hepatic",
"veins"
] |
[
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02964741
|
15:35:treatment,,
|
No overuse of analgesic medication, defined as regular intake on ≥15 days per month for more than 3 months
| 1
|
[
"No",
"overuse",
"of",
"analgesic",
"medication",
",",
"defined",
"as",
"regular",
"intake",
"on",
"≥15",
"days",
"per",
"month",
"for",
"more",
"than",
"3",
"months"
] |
[
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03179163
|
12:27:allergy_name
|
allergy to test substances
| 1
|
[
"allergy",
"to",
"test",
"substances"
] |
[
0,
0,
4,
4
] |
NCT01384513
|
1:29:treatment,,,,,
|
ematopoietic Cell Transplant-Comorbidity Index (HCT-CI) Score > 4 points for patients ≥ 60 years old or > 5 points for patients < 60
| 1
|
[
"ematopoietic",
"Cell",
"Transplant-Comorbidity",
"Index",
"(",
"HCT-CI",
")",
"Score",
">",
"4",
"points",
"for",
"patients",
"≥",
"60",
"years",
"old",
"or",
">",
"5",
"points",
"for",
"patients",
"<",
"60"
] |
[
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02639546
|
116:143:treatment,145:164:treatment,166:179:treatment
|
Measurable disease as defined by mINRC, RANO criteria for HGG, RANO criteria for LGG, RECIST v1.1, or evaluable by nuclear medicine techniques, immunocytochemistry, tumor markers, or other reliable measures
| 1
|
[
"Measurable",
"disease",
"as",
"defined",
"by",
"mINRC",
",",
"RANO",
"criteria",
"for",
"HGG",
",",
"RANO",
"criteria",
"for",
"LGG",
",",
"RECIST",
"v1.1",
",",
"or",
"evaluable",
"by",
"nuclear",
"medicine",
"techniques",
",",
"immunocytochemistry",
",",
"tumor",
"markers",
",",
"or",
"other",
"reliable",
"measures"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
1,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT03123783
|
15:39:cancer,67:81:treatment,89:110:treatment,120:143:treatment
|
Subjects with BRAF activating mutation could have also received a BRAF inhibitor and/or MEK inhibitor regimen prior to anti-PD-1/PD-L1 therapy
| 1
|
[
"Subjects",
"with",
"BRAF",
"activating",
"mutation",
"could",
"have",
"also",
"received",
"a",
"BRAF",
"inhibitor",
"and/or",
"MEK",
"inhibitor",
"regimen",
"prior",
"to",
"anti-PD-1/PD-L1",
"therapy"
] |
[
0,
0,
1,
1,
3,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
1,
1
] |
NCT02394535
|
34:64:cancer
|
Cytologic or histologic proof of adenocarcinoma of the pancreas
| 1
|
[
"Cytologic",
"or",
"histologic",
"proof",
"of",
"adenocarcinoma",
"of",
"the",
"pancreas"
] |
[
0,
0,
0,
0,
0,
3,
3,
3,
3
] |
NCT03153982
|
1:16:chronic_disease
|
Acute hepatitis
| 1
|
[
"Acute",
"hepatitis"
] |
[
2,
2
] |
NCT02508311
|
18:33:treatment
|
Currently taking corticosteroids
| 1
|
[
"Currently",
"taking",
"corticosteroids"
] |
[
0,
0,
1
] |
NCT01902810
|
23:67:chronic_disease,69:75:chronic_disease,85:113:chronic_disease
|
Currently treated for Chronic Obstructive Pulmonary Disease (COPD), asthma or other chronic pulmonary conditions
| 1
|
[
"Currently",
"treated",
"for",
"Chronic",
"Obstructive",
"Pulmonary",
"Disease",
"(",
"COPD",
")",
",",
"asthma",
"or",
"other",
"chronic",
"pulmonary",
"conditions"
] |
[
0,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
2,
0,
0,
2,
2,
2
] |
NCT02453113
|
12:15:chronic_disease
|
History of HIV
| 1
|
[
"History",
"of",
"HIV"
] |
[
0,
0,
2
] |
NCT02567422
|
,,,,,299:335:treatment,337:369:treatment,374:382:treatment
|
Patients must have measurable disease, defined as at least one lesion that can be accurately measured in at least one dimension (longest diameter to be recorded for non-nodal lesions and short axis for nodal lesions) as >= 20 mm (>= 2 cm) with conventional techniques or as >= 10 mm (>= 1 cm) with spiral computed tomography (CT) scan, magnetic resonance imaging (MRI), or calipers by clinical exam
| 1
|
[
"Patients",
"must",
"have",
"measurable",
"disease",
",",
"defined",
"as",
"at",
"least",
"one",
"lesion",
"that",
"can",
"be",
"accurately",
"measured",
"in",
"at",
"least",
"one",
"dimension",
"(",
"longest",
"diameter",
"to",
"be",
"recorded",
"for",
"non-nodal",
"lesions",
"and",
"short",
"axis",
"for",
"nodal",
"lesions",
")",
"as",
">",
"=",
"20",
"mm",
"(",
">",
"=",
"2",
"cm",
")",
"with",
"conventional",
"techniques",
"or",
"as",
">",
"=",
"10",
"mm",
"(",
">",
"=",
"1",
"cm",
")",
"with",
"spiral",
"computed",
"tomography",
"(",
"CT",
")",
"scan",
",",
"magnetic",
"resonance",
"imaging",
"(",
"MRI",
")",
",",
"or",
"calipers",
"by",
"clinical",
"exam"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02418195
|
1:13:treatment
|
Chemotherapy
| 1
|
[
"Chemotherapy"
] |
[
1
] |
NCT02555280
|
8:25:chronic_disease
|
Severe facet hypertrophy that requires extensive bone removal which would cause instability
| 1
|
[
"Severe",
"facet",
"hypertrophy",
"that",
"requires",
"extensive",
"bone",
"removal",
"which",
"would",
"cause",
"instability"
] |
[
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01526603
|
,,,,67:91:chronic_disease
|
shortening fraction ≥ 27% or ejection fraction ≥ 50%, no clinical congestive heart failure
| 1
|
[
"shortening",
"fraction",
"≥",
"27",
"%",
"or",
"ejection",
"fraction",
"≥",
"50",
"%",
",",
"no",
"clinical",
"congestive",
"heart",
"failure"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2
] |
NCT02207465
|
1:52:treatment,
|
Treatment with an investigational anti-cancer agent within 4 weeks prior to enrollment into the study
| 1
|
[
"Treatment",
"with",
"an",
"investigational",
"anti-cancer",
"agent",
"within",
"4",
"weeks",
"prior",
"to",
"enrollment",
"into",
"the",
"study"
] |
[
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02305537
|
26:64:chronic_disease
|
those who exhibit severe behavioral disinhibition or aggression
| 1
|
[
"those",
"who",
"exhibit",
"severe",
"behavioral",
"disinhibition",
"or",
"aggression"
] |
[
0,
0,
0,
0,
2,
2,
2,
2
] |
NCT02565498
|
12:22:cancer,64:84:cancer,100:117:cancer
|
concurrent malignancy with the exception of adequately treated basal cell carcinoma of the skin or carcinoma in-situ of the cervix
| 1
|
[
"concurrent",
"malignancy",
"with",
"the",
"exception",
"of",
"adequately",
"treated",
"basal",
"cell",
"carcinoma",
"of",
"the",
"skin",
"or",
"carcinoma",
"in-situ",
"of",
"the",
"cervix"
] |
[
0,
3,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02125786
|
23:44:cancer,,
|
Any patient with both metastatic ependymoma and age < 3 years at the time of enrollment
| 1
|
[
"Any",
"patient",
"with",
"both",
"metastatic",
"ependymoma",
"and",
"age",
"<",
"3",
"years",
"at",
"the",
"time",
"of",
"enrollment"
] |
[
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02151175
|
34:86:treatment,90:99:treatment,104:114:treatment,115:134:chronic_disease
|
Subjects who have been offered a non-dominant anterior-mesial temporal lobe resection as treatment for medication refractory epilepsy
| 1
|
[
"Subjects",
"who",
"have",
"been",
"offered",
"a",
"non-dominant",
"anterior-mesial",
"temporal",
"lobe",
"resection",
"as",
"treatment",
"for",
"medication",
"refractory",
"epilepsy"
] |
[
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
1,
0,
1,
2,
2
] |
NCT03152058
|
12:24:chronic_disease
|
History of tuberculosis or untreated positive PPD
| 1
|
[
"History",
"of",
"tuberculosis",
"or",
"untreated",
"positive",
"PPD"
] |
[
0,
0,
2,
0,
0,
0,
0
] |
NCT02770326
|
1:4:chronic_disease,,
|
HIV infection with CD4 count <240
| 1
|
[
"HIV",
"infection",
"with",
"CD4",
"count",
"<",
"240"
] |
[
2,
0,
0,
0,
0,
0,
0
] |
NCT02819843
|
,,76:102:treatment
|
History of high grade (CTCAE ≥ Grade 3) immune mediated adverse event from prior cancer immunotherapy
| 1
|
[
"History",
"of",
"high",
"grade",
"(",
"CTCAE",
"≥",
"Grade",
"3",
")",
"immune",
"mediated",
"adverse",
"event",
"from",
"prior",
"cancer",
"immunotherapy"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT00719888
|
11:35:treatment,
|
Any prior myeloablative transplant within the last 6 months
| 1
|
[
"Any",
"prior",
"myeloablative",
"transplant",
"within",
"the",
"last",
"6",
"months"
] |
[
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT03161028
|
9:34:chronic_disease,46:48:chronic_disease,56:62:cancer,64:77:chronic_disease,89:112:chronic_disease,114:144:chronic_disease
|
Current major disease or disorder other than MS (e.g., cancer, renal disease, end-stage cardiopulmonary disease, post-traumatic stress disorder, etc.) that may interfere with study procedures
| 1
|
[
"Current",
"major",
"disease",
"or",
"disorder",
"other",
"than",
"MS",
"(",
"e.g.",
",",
"cancer",
",",
"renal",
"disease",
",",
"end-stage",
"cardiopulmonary",
"disease",
",",
"post-traumatic",
"stress",
"disorder",
",",
"etc",
".",
")",
"that",
"may",
"interfere",
"with",
"study",
"procedures"
] |
[
0,
2,
2,
2,
2,
0,
0,
2,
0,
0,
0,
3,
0,
2,
2,
0,
0,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03181516
|
12:22:allergy_name
|
Allergy to strawberry
| 1
|
[
"Allergy",
"to",
"strawberry"
] |
[
0,
0,
4
] |
NCT02210650
|
9:16:treatment,
|
Current CT scan within the 90-day pre-operative period
| 1
|
[
"Current",
"CT",
"scan",
"within",
"the",
"90-day",
"pre-operative",
"period"
] |
[
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02479698
|
21:44:chronic_disease
|
Patients with other uncontrolled infections
| 1
|
[
"Patients",
"with",
"other",
"uncontrolled",
"infections"
] |
[
0,
0,
0,
2,
2
] |
NCT02765633
|
38:62:chronic_disease,,,,,,,,
|
Participants with evidence of severe hepatic or renal failure [aspartate aminotransferase (AST) or alanine aminotransferase (ALT) greater than three times normal for age or total bilirubin greater than 20 milligrams (mg)/deciliter (dL); creatinine greater than 2 times the normal upper limit]
| 1
|
[
"Participants",
"with",
"evidence",
"of",
"severe",
"hepatic",
"or",
"renal",
"failure",
"[",
"aspartate",
"aminotransferase",
"(",
"AST",
")",
"or",
"alanine",
"aminotransferase",
"(",
"ALT",
")",
"greater",
"than",
"three",
"times",
"normal",
"for",
"age",
"or",
"total",
"bilirubin",
"greater",
"than",
"20",
"milligrams",
"(",
"mg",
")",
"/deciliter",
"(",
"dL",
")",
";",
"creatinine",
"greater",
"than",
"2",
"times",
"the",
"normal",
"upper",
"limit",
"]"
] |
[
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02233322
|
1:25:chronic_disease,32:46:chronic_disease,48:57:chronic_disease
|
severe end-organ disease, e.g. cardiovascular, pulmonary, etc, which may limit ability to complete study
| 1
|
[
"severe",
"end-organ",
"disease",
",",
"e.g",
".",
"cardiovascular",
",",
"pulmonary",
",",
"etc",
",",
"which",
"may",
"limit",
"ability",
"to",
"complete",
"study"
] |
[
2,
2,
2,
0,
0,
0,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02496208
|
97:109:treatment,,322:355:treatment,373:391:treatment,427:438:treatment,,,,,,,,946:963:treatment,
|
The effects of the drugs used in this trial on the developing human fetus are unknown; however, cabozantinib was embryolethal in rats at exposures below the 140mg dose in the label, with increased incidences of skeletal variations in rats and visceral variations and malformations in rabbits; for this reason and because tyrosine kinase inhibitors agents as well as other therapeutic agents used in this trial are known to be teratogenic, women of child-bearing potential and men must agree to use adequate contraception, as defined below, prior to study entry and for the duration of study participation; should a woman become pregnant or suspect she is pregnant while she is participating in this study, she should inform her treating physician immediately; men treated or enrolled on this protocol must also agree to use adequate contraception prior to the study, for the duration of study participation, and 7 months after completion of all study medications; women treated or enrolled on this protocol must also agree to use adequate contraception prior to the study, for the duration of study participation, and for 5 months after completion of all study medications
| 1
|
[
"The",
"effects",
"of",
"the",
"drugs",
"used",
"in",
"this",
"trial",
"on",
"the",
"developing",
"human",
"fetus",
"are",
"unknown",
";",
"however",
",",
"cabozantinib",
"was",
"embryolethal",
"in",
"rats",
"at",
"exposures",
"below",
"the",
"140mg",
"dose",
"in",
"the",
"label",
",",
"with",
"increased",
"incidences",
"of",
"skeletal",
"variations",
"in",
"rats",
"and",
"visceral",
"variations",
"and",
"malformations",
"in",
"rabbits",
";",
"for",
"this",
"reason",
"and",
"because",
"tyrosine",
"kinase",
"inhibitors",
"agents",
"as",
"well",
"as",
"other",
"therapeutic",
"agents",
"used",
"in",
"this",
"trial",
"are",
"known",
"to",
"be",
"teratogenic",
",",
"women",
"of",
"child-bearing",
"potential",
"and",
"men",
"must",
"agree",
"to",
"use",
"adequate",
"contraception",
",",
"as",
"defined",
"below",
",",
"prior",
"to",
"study",
"entry",
"and",
"for",
"the",
"duration",
"of",
"study",
"participation",
";",
"should",
"a",
"woman",
"become",
"pregnant",
"or",
"suspect",
"she",
"is",
"pregnant",
"while",
"she",
"is",
"participating",
"in",
"this",
"study",
",",
"she",
"should",
"inform",
"her",
"treating",
"physician",
"immediately",
";",
"men",
"treated",
"or",
"enrolled",
"on",
"this",
"protocol",
"must",
"also",
"agree",
"to",
"use",
"adequate",
"contraception",
"prior",
"to",
"the",
"study",
",",
"for",
"the",
"duration",
"of",
"study",
"participation",
",",
"and",
"7",
"months",
"after",
"completion",
"of",
"all",
"study",
"medications",
";",
"women",
"treated",
"or",
"enrolled",
"on",
"this",
"protocol",
"must",
"also",
"agree",
"to",
"use",
"adequate",
"contraception",
"prior",
"to",
"the",
"study",
",",
"for",
"the",
"duration",
"of",
"study",
"participation",
",",
"and",
"for",
"5",
"months",
"after",
"completion",
"of",
"all",
"study",
"medications"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01433965
|
1:37:chronic_disease
|
Impaired gastrointestinal absorption
| 1
|
[
"Impaired",
"gastrointestinal",
"absorption"
] |
[
2,
2,
2
] |
NCT02581215
|
29:38:treatment
|
Known allergy to any of the treatment components
| 1
|
[
"Known",
"allergy",
"to",
"any",
"of",
"the",
"treatment",
"components"
] |
[
0,
0,
0,
0,
0,
0,
1,
0
] |
NCT00737893
|
30:56:chronic_disease
|
The patient has a history of high or low blood pressure that is not controlled
| 1
|
[
"The",
"patient",
"has",
"a",
"history",
"of",
"high",
"or",
"low",
"blood",
"pressure",
"that",
"is",
"not",
"controlled"
] |
[
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0
] |
NCT02419495
|
18:54:treatment
|
must have failed prior standard curative chemotherapy for their disease
| 1
|
[
"must",
"have",
"failed",
"prior",
"standard",
"curative",
"chemotherapy",
"for",
"their",
"disease"
] |
[
0,
0,
0,
1,
1,
1,
1,
0,
0,
0
] |
NCT00630565
|
29:57:treatment,82:105:treatment,129:147:treatment
|
Patients who cannot receive total body irradiation (TBI) (for example those with prior radiation therapy) will also receive the Bu/CY conditioning
| 1
|
[
"Patients",
"who",
"can",
"not",
"receive",
"total",
"body",
"irradiation",
"(",
"TBI",
")",
"(",
"for",
"example",
"those",
"with",
"prior",
"radiation",
"therapy",
")",
"will",
"also",
"receive",
"the",
"Bu/CY",
"conditioning"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
1,
1
] |
NCT03006770
|
12:22:cancer,
|
history of malignancy within 5 years prior to study entry
| 1
|
[
"history",
"of",
"malignancy",
"within",
"5",
"years",
"prior",
"to",
"study",
"entry"
] |
[
0,
0,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT03037983
|
8:19:chronic_disease,21:37:chronic_disease,47:84:chronic_disease,100:122:chronic_disease
|
Have a mass lesion, cerebral infarct or other active central nervous system disease, or history of traumatic brain injury
| 1
|
[
"Have",
"a",
"mass",
"lesion",
",",
"cerebral",
"infarct",
"or",
"other",
"active",
"central",
"nervous",
"system",
"disease",
",",
"or",
"history",
"of",
"traumatic",
"brain",
"injury"
] |
[
0,
0,
2,
2,
0,
2,
2,
0,
0,
2,
2,
2,
2,
2,
0,
0,
0,
0,
2,
2,
2
] |
NCT02481765
|
66:78:treatment
|
Intensive medical treatment means that the subject is undergoing chemotherapy for a hematologic/oncologic condition, is carrying a pacemaker or has been diagnosed with a cardiac anomaly which causes cardiac insufficiency not compensated with medications
| 1
|
[
"Intensive",
"medical",
"treatment",
"means",
"that",
"the",
"subject",
"is",
"undergoing",
"chemotherapy",
"for",
"a",
"hematologic/oncologic",
"condition",
",",
"is",
"carrying",
"a",
"pacemaker",
"or",
"has",
"been",
"diagnosed",
"with",
"a",
"cardiac",
"anomaly",
"which",
"causes",
"cardiac",
"insufficiency",
"not",
"compensated",
"with",
"medications"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02346929
|
1:9:chronic_disease
|
dementia
| 1
|
[
"dementia"
] |
[
2
] |
NCT03109431
|
1:4:chronic_disease
|
HIV-positive serostatus
| 1
|
[
"HIV-positive",
"serostatus"
] |
[
2,
0
] |
NCT02541565
|
,,,80:88:cancer
|
emoglobin >= 9 g/dL or >= 5.6 mmol/L except in cases of marrow infiltration by lymphoma
| 1
|
[
"emoglobin",
">",
"=",
"9",
"g/dL",
"or",
">",
"=",
"5.6",
"mmol/L",
"except",
"in",
"cases",
"of",
"marrow",
"infiltration",
"by",
"lymphoma"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3
] |
NCT03135522
|
14:25:cancer
|
negative for lung cancer
| 1
|
[
"negative",
"for",
"lung",
"cancer"
] |
[
0,
0,
3,
3
] |
NCT02487095
|
43:70:chronic_disease
|
Subjects with both platinum-sensitive and platinum-refractory disease
| 1
|
[
"Subjects",
"with",
"both",
"platinum-sensitive",
"and",
"platinum-refractory",
"disease"
] |
[
0,
0,
0,
0,
0,
2,
2
] |
NCT02404194
|
,13:22:chronic_disease
|
One or more psychosis-risk syndromes as defined by the Structured Interview for Psychosis-Risk Syndromes (SIPS)
| 1
|
[
"One",
"or",
"more",
"psychosis-risk",
"syndromes",
"as",
"defined",
"by",
"the",
"Structured",
"Interview",
"for",
"Psychosis-Risk",
"Syndromes",
"(",
"SIPS",
")"
] |
[
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02542657
|
,121:128:cancer,
|
For patients without a measurable serum or urine M-component or serum free light chain level: % marrow involvement with myeloma (absolute increase must be >= 10%)
| 1
|
[
"For",
"patients",
"without",
"a",
"measurable",
"serum",
"or",
"urine",
"M-component",
"or",
"serum",
"free",
"light",
"chain",
"level",
":",
"%",
"marrow",
"involvement",
"with",
"myeloma",
"(",
"absolute",
"increase",
"must",
"be",
">",
"=",
"10",
"%",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01333046
|
20:44:treatment
|
Patients receiving systemic corticosteroids
| 1
|
[
"Patients",
"receiving",
"systemic",
"corticosteroids"
] |
[
0,
0,
1,
1
] |
NCT03131037
|
1:33:chronic_disease
|
end-stage liver or renal disease
| 1
|
[
"end-stage",
"liver",
"or",
"renal",
"disease"
] |
[
2,
2,
2,
2,
2
] |
NCT02762006
|
1:31:chronic_disease
|
controlled atrial fibrillation
| 1
|
[
"controlled",
"atrial",
"fibrillation"
] |
[
2,
2,
2
] |
NCT02753283
|
62:71:treatment
|
Those with a history of hypocalcemia or contraindication for treatment
| 1
|
[
"Those",
"with",
"a",
"history",
"of",
"hypocalcemia",
"or",
"contraindication",
"for",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT03113760
|
25:76:chronic_disease
|
Patients suffering from familial hemophagocytic lymphohistiocytosis (f HLH)
| 1
|
[
"Patients",
"suffering",
"from",
"familial",
"hemophagocytic",
"lymphohistiocytosis",
"(",
"f",
"HLH",
")"
] |
[
0,
0,
0,
2,
2,
2,
2,
2,
0,
0
] |
NCT02277613
|
10:32:treatment
|
Previous solid organ transplant
| 1
|
[
"Previous",
"solid",
"organ",
"transplant"
] |
[
0,
1,
1,
1
] |
NCT02016924
|
,,111:120:treatment
|
females of childbearing potential must agree to utilize highly effective contraception methods while on study treatment or agree to abstain from heterosexual intercourse throughout the study period
| 1
|
[
"females",
"of",
"childbearing",
"potential",
"must",
"agree",
"to",
"utilize",
"highly",
"effective",
"contraception",
"methods",
"while",
"on",
"study",
"treatment",
"or",
"agree",
"to",
"abstain",
"from",
"heterosexual",
"intercourse",
"throughout",
"the",
"study",
"period"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02669173
|
1:55:chronic_disease
|
Active infection with hepatitis B or hepatitis C virus
| 1
|
[
"Active",
"infection",
"with",
"hepatitis",
"B",
"or",
"hepatitis",
"C",
"virus"
] |
[
2,
2,
2,
2,
2,
2,
2,
2,
2
] |
NCT03082612
|
46:58:treatment
|
Treatment plans to include weekly outpatient chemotherapy
| 1
|
[
"Treatment",
"plans",
"to",
"include",
"weekly",
"outpatient",
"chemotherapy"
] |
[
0,
0,
0,
0,
0,
0,
1
] |
NCT01306045
|
38:62:chronic_disease
|
Ongoing or uncontrolled, symptomatic congestive heart failure (Class III or IV as defined by the NYHA functional classification system
| 1
|
[
"Ongoing",
"or",
"uncontrolled",
",",
"symptomatic",
"congestive",
"heart",
"failure",
"(",
"Class",
"III",
"or",
"IV",
"as",
"defined",
"by",
"the",
"NYHA",
"functional",
"classification",
"system"
] |
[
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02124772
|
,,83:104:treatment,
|
platelets >=75,000/ microliter (transfusion independent, defined as not receiving platelet transfusions within a 7 day period prior to enrollment)
| 1
|
[
"platelets",
">",
"=75,000/",
"microliter",
"(",
"transfusion",
"independent",
",",
"defined",
"as",
"not",
"receiving",
"platelet",
"transfusions",
"within",
"a",
"7",
"day",
"period",
"prior",
"to",
"enrollment",
")"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02567422
|
33:36:chronic_disease
|
patients with poorly controlled HIV
| 1
|
[
"patients",
"with",
"poorly",
"controlled",
"HIV"
] |
[
0,
0,
0,
0,
2
] |
NCT03088709
|
,78:90:treatment
|
Less than twenty-one days have elapsed since the subject's last radiation or chemotherapy prior to conditioning
| 1
|
[
"Less",
"than",
"twenty-one",
"days",
"have",
"elapsed",
"since",
"the",
"subject",
"'s",
"last",
"radiation",
"or",
"chemotherapy",
"prior",
"to",
"conditioning"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02468453
|
26:71:chronic_disease,83:96:chronic_disease,100:104:chronic_disease,125:154:treatment
|
Subject has a history of immunosuppression/immune deficiency disorders (including HIV infection or AIDS) or currently using immunosuppressive medications
| 1
|
[
"Subject",
"has",
"a",
"history",
"of",
"immunosuppression/immune",
"deficiency",
"disorders",
"(",
"including",
"HIV",
"infection",
"or",
"AIDS",
")",
"or",
"currently",
"using",
"immunosuppressive",
"medications"
] |
[
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
2,
2,
0,
2,
0,
0,
0,
0,
1,
1
] |
NCT02548104
|
1:19:chronic_disease
|
Systemic infection
| 1
|
[
"Systemic",
"infection"
] |
[
2,
2
] |
NCT02739035
|
1:18:chronic_disease
|
Renal dysfunction
| 1
|
[
"Renal",
"dysfunction"
] |
[
2,
2
] |
NCT02481713
|
14:32:chronic_disease
|
diagnosis of psychotic disorder
| 1
|
[
"diagnosis",
"of",
"psychotic",
"disorder"
] |
[
0,
0,
2,
2
] |
NCT02542202
|
32:55:treatment
|
Patients may not have received prior radiation therapy to a site of recurrence which would require overlap of appreciable radiation dose
| 1
|
[
"Patients",
"may",
"not",
"have",
"received",
"prior",
"radiation",
"therapy",
"to",
"a",
"site",
"of",
"recurrence",
"which",
"would",
"require",
"overlap",
"of",
"appreciable",
"radiation",
"dose"
] |
[
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02632422
|
1:10:chronic_disease,17:24:chronic_disease,27:39:chronic_disease,41:63:chronic_disease,65:82:chronic_disease,84:103:chronic_disease,135:159:chronic_disease,200:216:chronic_disease
|
infection (e.g. bladder), hypertension, cardiovascular disease, pulmonary disease, severe osteoporosis (history of fractures), active heterotopic ossification in the lower extremities, or history of peripheral nerve injury in the legs
| 1
|
[
"infection",
"(",
"e.g",
".",
"bladder",
")",
",",
"hypertension",
",",
"cardiovascular",
"disease",
",",
"pulmonary",
"disease",
",",
"severe",
"osteoporosis",
"(",
"history",
"of",
"fractures",
")",
",",
"active",
"heterotopic",
"ossification",
"in",
"the",
"lower",
"extremities",
",",
"or",
"history",
"of",
"peripheral",
"nerve",
"injury",
"in",
"the",
"legs"
] |
[
2,
0,
0,
0,
2,
0,
0,
2,
0,
2,
2,
0,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0
] |
NCT02565199
|
12:22:chronic_disease,,
|
No current depression (score less than 7 on the Hamilton Depression Rating Scale (HDRS))
| 1
|
[
"No",
"current",
"depression",
"(",
"score",
"less",
"than",
"7",
"on",
"the",
"Hamilton",
"Depression",
"Rating",
"Scale",
"(",
"HDRS",
")",
")"
] |
[
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02496208
|
,68:77:treatment
|
To any other site(s) within 28 days before the first dose of study treatment
| 1
|
[
"To",
"any",
"other",
"site",
"(",
"s",
")",
"within",
"28",
"days",
"before",
"the",
"first",
"dose",
"of",
"study",
"treatment"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01999179
|
55:70:treatment
|
Participation in another clinical trial that requires anticoagulation
| 1
|
[
"Participation",
"in",
"another",
"clinical",
"trial",
"that",
"requires",
"anticoagulation"
] |
[
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02494869
|
1:20:chronic_disease
|
Respiratory failure
| 1
|
[
"Respiratory",
"failure"
] |
[
2,
2
] |
NCT03120728
|
28:41:cancer
|
current or past history of breast cancer
| 1
|
[
"current",
"or",
"past",
"history",
"of",
"breast",
"cancer"
] |
[
0,
0,
0,
0,
0,
3,
3
] |
NCT01420887
|
28:31:treatment,35:65:treatment,75:93:chronic_disease,102:116:treatment
|
Contraindication to use of CPM or regional brachial plexus block, such as bleeding diathesis, use of anticoagulants or severe restriction in shoulder range of movement
| 1
|
[
"Contraindication",
"to",
"use",
"of",
"CPM",
"or",
"regional",
"brachial",
"plexus",
"block",
",",
"such",
"as",
"bleeding",
"diathesis",
",",
"use",
"of",
"anticoagulants",
"or",
"severe",
"restriction",
"in",
"shoulder",
"range",
"of",
"movement"
] |
[
0,
0,
0,
0,
1,
0,
1,
1,
1,
1,
0,
0,
0,
2,
2,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01730118
|
10:36:treatment,39:62:treatment,68:89:treatment,92:130:treatment,141:164:treatment
|
Naive to trastuzumab (Herceptin(TM)), pertuzumab (Perjeta(TM)) and lapatinib (Tykerb(TM)), ado-trastuzumab emtansine (Kadcyla(TM)) or other HER2-directed therapies
| 1
|
[
"Naive",
"to",
"trastuzumab",
"(",
"Herceptin",
"(",
"TM",
")",
")",
",",
"pertuzumab",
"(",
"Perjeta",
"(",
"TM",
")",
")",
"and",
"lapatinib",
"(",
"Tykerb",
"(",
"TM",
")",
")",
",",
"ado-trastuzumab",
"emtansine",
"(",
"Kadcyla",
"(",
"TM",
")",
")",
"or",
"other",
"HER2-directed",
"therapies"
] |
[
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03060096
|
16:25:chronic_disease,
|
Self -reported psychotic symptoms in the last 30 days
| 1
|
[
"Self",
"-reported",
"psychotic",
"symptoms",
"in",
"the",
"last",
"30",
"days"
] |
[
0,
0,
2,
0,
0,
0,
0,
0,
0
] |
NCT02466971
|
29:80:chronic_disease
|
Patient does not have known glucose‐6‐phosphate dehydrogenase (G6PD) deficiency (G6PD testing optional)
| 1
|
[
"Patient",
"does",
"not",
"have",
"known",
"glucose‐6‐phosphate",
"dehydrogenase",
"(",
"G6PD",
")",
"deficiency",
"(",
"G6PD",
"testing",
"optional",
")"
] |
[
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02265874
|
57:68:chronic_disease,
|
Eligible adult patients will have histologically proven sarcoidosis, diagnosed at least 6 months before screening
| 1
|
[
"Eligible",
"adult",
"patients",
"will",
"have",
"histologically",
"proven",
"sarcoidosis",
",",
"diagnosed",
"at",
"least",
"6",
"months",
"before",
"screening"
] |
[
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01570816
|
29:38:chronic_disease,
|
problems walking because of paralysis for more than 6 months
| 1
|
[
"problems",
"walking",
"because",
"of",
"paralysis",
"for",
"more",
"than",
"6",
"months"
] |
[
0,
0,
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT02257424
|
24:43:chronic_disease
|
Subjects with moderate valvular thickening
| 1
|
[
"Subjects",
"with",
"moderate",
"valvular",
"thickening"
] |
[
0,
0,
0,
2,
2
] |
NCT00980538
|
50:62:chronic_disease,64:83:chronic_disease,238:247:treatment,253:256:treatment
|
Any active clinically significant disease (e.g., pancreatitis, cardiac dysfunction) or findings of medical history, laboratory or physical examination that, in the investigator's opinion, would compromise the participant's safety during treatment with ETR
| 1
|
[
"Any",
"active",
"clinically",
"significant",
"disease",
"(",
"e.g.",
",",
"pancreatitis",
",",
"cardiac",
"dysfunction",
")",
"or",
"findings",
"of",
"medical",
"history",
",",
"laboratory",
"or",
"physical",
"examination",
"that",
",",
"in",
"the",
"investigator",
"'s",
"opinion",
",",
"would",
"compromise",
"the",
"participant",
"'s",
"safety",
"during",
"treatment",
"with",
"ETR"
] |
[
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1
] |
NCT01942018
|
1:32:chronic_disease
|
Acute gastrointestinal bleeding
| 1
|
[
"Acute",
"gastrointestinal",
"bleeding"
] |
[
2,
2,
2
] |
NCT03056339
|
13:44:chronic_disease
|
Presence of active neurological disorder(s)
| 1
|
[
"Presence",
"of",
"active",
"neurological",
"disorder",
"(",
"s",
")"
] |
[
0,
0,
2,
2,
2,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.